References
- Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1-2, 19–25. https://doi.org/https://doi.org/10.1016/j.softx.2015.06.001
- Ahmad, T., Khan, M., Haroon; Musa, T. H., Nasir, S., Hui, J., Bonilla-Aldana, D. K., & Rodriguez-Morales, A. J. (2020). COVID-19: Zoonotic aspects. Travel Medicine and Infectious Disease, 36, 101607. https://doi.org/https://doi.org/10.1016/j.tmaid.2020.101607
- Baby, K., Maity, S., Mehta, C. H., Suresh, A., Nayak, U. Y., & Nayak, Y. (2020). Targeting SARS-CoV-2 main protease: A computational drug repurposing study. Archives of Medical Research, S0188440920309577. https://doi.org/https://doi.org/10.1016/j.arcmed.2020.09.013
- Barisione, G., Baroffio, M., Crimi, E., & Brusasco, V. (2010). Beta-adrenergic agonists. Pharmaceuticals (Basel, Switzerland), 3(4), 1016–1044. https://doi.org/https://doi.org/10.3390/ph3041016
- Bolelli, K., Ertan-Bolelli, T., Unsalan, O., & Altunayar-Unsalan, C. (2020). Altunayar-unsalan, C. fenoterol and dobutamine as COVID-19 main protease inhibitors: A virtual screening study. Journal of Molecular Structure, 129449. https://doi.org/https://doi.org/10.1016/j.molstruc.2020.129449
- Bussi, G., Donadio, D., & Parrinello, M. (2007). Canonical sampling through velocity rescaling. The Journal of Chemical Physics, 126(1), 014101. https://doi.org/https://doi.org/10.1063/1.2408420
- Chojnacka, K., Witek-Krowiak, A., Skrzypczak, D., Mikula, K., & Młynarz, P. (2020). Phytochemicals containing biologically active polyphenols as an effective agent against Covid-19-inducing coronavirus. The Journal of Functional Foods, 73, 104146. https://doi.org/https://doi.org/10.1016/j.jff.2020.104146
- Daddam, J. R., Sreenivasulu, B., Peddanna, K., & Umamahesh, K. (2020). Designing, docking and molecular dynamics simulation studies of novel cloperastine analogues as anti-allergic agents: Homology modeling and active site prediction for the human histamine H1 receptor. RSC Advances, 10(8), 4745–4754. https://doi.org/https://doi.org/10.1039/C9RA09245E
- Das, B. K., Pv, P., & Chakraborty, D. (2019). Computational insights into factor affecting the potency of diaryl sulfone analogs as Escherichia coli dihydropteroate synthase inhibitors. Computational Biology and Chemistry, 78, 37–52. https://doi.org/https://doi.org/10.1016/j.compbiolchem.2018.11.005
- Dixon, S. L., Smondyrev, A. M., Knoll, E. H., Rao, S. N., Shaw, D. E., & Friesner, R. A. (2006). PHASE: A new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. Journal of Computer-Aided Molecular Design, 20(10-11), 647–671. https://doi.org/https://doi.org/10.1007/s10822-006-9087-6
- Fehr, A. R., & Perlman, S. (2015). Coronaviruses: An overview of their replication and pathogenesis. In Maier, H. J., Bickerton, E., & Britton, P. (Eds.), Methods in molecular biology (Vol. 1282, pp 1–23). New York: Springer. https://doi.org/https://doi.org/10.1007/978-1-4939-2438-7_1
- Glazer, R. I. (1980). Adenosine deaminase inhibitors: Their role in chemotherapy and immunosuppression. Cancer Chemotherapy and Pharmacology, 4(4), 227-235. https://doi.org/https://doi.org/10.1007/BF00255266
- Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O'Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., Tummino, T. A., Hüttenhain, R., Kaake, R. M., Richards, A. L., Tutuncuoglu, B., Foussard, H., Batra, J., Haas, K., Modak, M., … Krogan, N. J. (2020). A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature, 583(7816), 459–468. https://doi.org/https://doi.org/10.1038/s41586-020-2286-9
- Gutierrez-Villagomez, J. M., Campos-García, T., Molina Torres, J., López, M. G., & Vázquez-Martínez, J. (2020). Alkamides and piperamides as potential antivirals against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The Journal of Physical Chemistry Letters, 11(19), 8008–8016. acs.jpclett.0c01685. https://doi.org/https://doi.org/10.1021/acs.jpclett.0c01685
- Hornak, V., Abel, R., Okur, A., Strockbine, B., Roitberg, A., & Simmerling, C. (2006). Comparison of multiple amber force fields and development of improved protein backbone parameters. Proteins, 65(3), 712–725. https://doi.org/https://doi.org/10.1002/prot.21123
- Irwin, J. J., Sterling, T., Mysinger, M. M., Bolstad, E. S., & Coleman, R. G. (2012). ZINC: A free tool to discover chemistry for biology. Journal of Chemical Information and Modeling, 52(7), 1757–1768. https://doi.org/https://doi.org/10.1021/ci3001277
- Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., Duan, Y., Yu, J., Wang, L., Yang, K., Liu, F., Jiang, R., Yang, X., You, T., Liu, X., … Yang, H. (2020). Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature, 582(7811), 289–293. https://doi.org/https://doi.org/10.1038/s41586-020-2223-y
- Jorgensen, W. L., Maxwell, D. S., & Tirado-Rives, J. (1996). Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. Journal of the American Chemical Society, 118(45), 11225–11236. https://doi.org/https://doi.org/10.1021/ja9621760
- Kaminski, G. A., Friesner, R. A., Tirado-Rives, J., & Jorgensen, W. L. (2001). Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides. The Journal of Physical Chemistry B, 105(28), 6474–6487. https://doi.org/https://doi.org/10.1021/jp003919d
- Kumar, D., Kumari, K., Vishvakarma, V. K., Jayaraj, A., Kumar, D., Ramappa, V. K., Patel, R., Kumar, V., Dass, S. K., & Chandra, R. (2020). Promising inhibitors of main protease of novel corona virus to prevent the spread of COVID-19 using docking and molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics, 1–15. https://doi.org/https://doi.org/10.1080/07391102.2020.1779131
- Kumar, Y., Singh, H., & Patel, C. N. (2020). In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing. Journal of Infection and Public Health, 13(9), 1210–1223. S1876034120305268. https://doi.org/https://doi.org/10.1016/j.jiph.2020.06.016
- Kumari, R., Kumar, R., & Lynn, A., Open Source Drug Discovery Consortium. (2014). g_mmpbsa-a GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951–1962. https://doi.org/https://doi.org/10.1021/ci500020m
- Li, S., & Hong, M. (2011). Protonation, tautomerization, and rotameric structure of histidine: A comprehensive study by magic-angle-spinning solid-state NMR. Journal of the American Chemical Society, 133(5), 1534–1544. https://doi.org/https://doi.org/10.1021/ja108943n
- Lipinski, C. A. (2004). Lead- and drug-like compounds: The rule-of-five revolution. Drug Discovery Today. Technologies, 1(4), 337–341. https://doi.org/https://doi.org/10.1016/j.ddtec.2004.11.007
- Mark, P., & Nilsson, L. (2001). Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K. The Journal of Physical Chemistry A, 105(43), 9954–9960. https://doi.org/https://doi.org/10.1021/jp003020w
- Martyna, G. J., Klein, M. L., & Tuckerman, M. (1992). Nosé–Hoover Chains: The Canonical Ensemble via Continuous Dynamics. The Journal of Chemical Physics, 97(4), 2635–2643. https://doi.org/https://doi.org/10.1063/1.463940
- Mittal, L., Kumari, A., Srivastava, M., Singh, M., & Asthana, S. (2020). Identification of potential molecules against COVID-19 main protease through structure-guided virtual screening approach. Journal of Biomolecular Structure and Dynamics, 1–19. https://doi.org/https://doi.org/10.1080/07391102.2020.1768151.
- Narkhede, R. R., Pise, A. V., Cheke, R. S., & Shinde, S. D. (2020). Recognition of natural products as potential inhibitors of COVID-19 Main Protease (Mpro): In-silico evidences. Natural Products and Bioprospecting, 10(5), 297–306. https://doi.org/https://doi.org/10.1007/s13659-020-00253-1
- Parrinello, M., & Rahman, A. (1981). Polymorphic transitions in single crystals: A new molecular dynamics method. Journal of Applied Physics, 52(12), 7182–7190. https://doi.org/https://doi.org/10.1063/1.328693
- Ren, X., Zeng, R., Wang, C., Zhang, M., Liang, C., Tang, Z., & Ren, J. (2017). Structural insight into inhibition of REV7 protein interaction revealed by docking, molecular dynamics and MM/PBSA studies. RSC Advances, 7(44), 27780–27786. https://doi.org/https://doi.org/10.1039/C7RA03716C
- Riva, L., Yuan, S., Yin, X., Martin-Sancho, L., Matsunaga, N., Pache, L., Burgstaller-Muehlbacher, S., De Jesus, P. D., Teriete, P., Hull, M. V., Chang, M. W., Chan, J. F.-W., Cao, J., Poon, V. K.-M., Herbert, K. M., Cheng, K., Nguyen, T.-T H., Rubanov, A., Pu, Y., … Chanda, S. K. (2020). Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Nature, 586(7827), 113–119. https://doi.org/https://doi.org/10.1038/s41586-020-2577-1
- Schoeman, D., & Fielding, B. C. (2019). Coronavirus envelope protein: Current knowledge. Virology Journal, 16(1), 69. https://doi.org/https://doi.org/10.1186/s12985-019-1182-0
- Shah, B., Modi, P., & Sagar, S. R. (2020). In silico studies on therapeutic agents for COVID-19: Drug repurposing approach. Life Sciences, 252, 117652. https://doi.org/https://doi.org/10.1016/j.lfs.2020.117652
- Svedmyr, N. (1985). Fenoterol: A beta2-adrenergic agonist for use in asthma. Pharmacology, pharmacokinetics, clinical efficacy and adverse effects. Pharmacotherapy, 5(3), 109–126. https://doi.org/https://doi.org/10.1002/j.1875-9114.1985.tb03409.x
- Terasaka, T., Kinoshita, T., Kuno, M., & Nakanishi, I. (2004). A highly potent non-nucleoside adenosine deaminase inhibitor: efficient drug discovery by intentional lead hybridization. Journal of the American Chemical Society, 126(1), 34–35. https://doi.org/https://doi.org/10.1021/ja038606l
- Terasaka, T., Kinoshita, T., Kuno, M., Seki, N., Tanaka, K., & Nakanishi, I. (2004). Structure-based design, synthesis, and structure-activity relationship studies of novel non-nucleoside adenosine deaminase inhibitors. Journal of Medicinal Chemistry, 47(15), 3730–3743. https://doi.org/https://doi.org/10.1021/jm0306374
- Trincavelli, M. L. (2013). Unveiling the binding mode of adenosine deaminase inhibitors to the active site of the enzyme: Implication for rational drug design : Presented by Maria P. Abbracchio. Purinergic Signalling, 9(1), 1–3. https://doi.org/https://doi.org/10.1007/s11302-013-9353-8
- Venugopal, P. P., Das, B. K., Soorya, E., & Chakraborty, D. (2020). Effect of hydrophobic and hydrogen bonding interactions on the potency of SS‐alanine analogs of G‐protein coupled glucagon receptor inhibitors. Proteins: Structure, Function, and Bioinformatics, 88(2), 327–344. https://doi.org/https://doi.org/10.1002/prot.25807
- Wang, F., Chen, C., Tan, W., Yang, K., & Yang, H. (2016). Structure of main protease from human Coronavirus NL63: Insights for wide spectrum anti-Coronavirus drug design. Scientific Reports, 6(1), 22677. https://doi.org/https://doi.org/10.1038/srep22677
- Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., Yuan, M.-L., Zhang, Y.-L., Dai, F.-H., Liu, Y., Wang, Q.-M., Zheng, J.-J., Xu, L., Holmes, E. C., & Zhang, Y.-Z. (2020). A new coronavirus associated with human respiratory disease in China. Nature, 579(7798), 265–269. https://doi.org/https://doi.org/10.1038/s41586-020-2008-3
- Xue, X., Yu, H., Yang, H., Xue, F., Wu, Z., Shen, W., Li, J., Zhou, Z., Ding, Y., Zhao, Q., Zhang, X. C., Liao, M., Bartlam, M., & Rao, Z. (2008). Structures of two coronavirus main proteases: Implications for substrate binding and antiviral drug design. Journal of Virology, 82(5), 2515–2527. https://doi.org/https://doi.org/10.1128/JVI.02114-07
- Yang, H., Yang, M., Ding, Y., Liu, Y., Lou, Z., Zhou, Z., Sun, L., Mo, L., Ye, S., Pang, H., Gao, G. F., Anand, K., Bartlam, M., Hilgenfeld, R., & Rao, Z. (2003). The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proceedings of the National Academy of Sciences of the United States of America, 100(23), 13190–13195. https://doi.org/https://doi.org/10.1073/pnas.1835675100
- Zhou, Y., Wang, F., Tang, J., Nussinov, R., & Cheng, F. (2020). Artificial intelligence in COVID-19 drug repurposing. The Lancet Digital Health, 2(12), e667–e676. S2589750020301928. https://doi.org/https://doi.org/10.1016/S2589-7500(20)30192-8